Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
Objectives We hypothesise that women with type 2 diabetes and hypertension are less likely than comparable men to receive renin–angiotensin system (RAS)-inhibiting antihypertensive treatment, ...
Site Burden Index (SBI), and standards-of-care data into its modeling and execution, SubjectWell is redefining how sponsors design protocols, forecast feasibility, drive enrollment, and sustain ...
Medicus Pharma Ltd. (Nasdaq:MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical ...
As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...
Chen: Yes, obesity is experiencing accelerated growth over the last couple of years. According to our sister product Evaluate ...
Parkinson’s Disease (PD) remains the second most prevalent neurodegenerative disorder worldwide, yet it continues to evade a definitive disease-modifying ...
At present evidence-based medicine is guided by the rules and regulations particularly of ethics and moral rights given which ...
Objective To assess the magnitude and associated factors of suicidal behaviour and non-suicidal self-injury (NSSI) among ...
The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...
Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single ...
With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback